News

Scivita Medical’s Headquarters, R&D and Manufacturing Plant Officially Opened

by

SUZHOU, China, June 2, 2023 /PRNewswire/ — On June 2, 2023 (Beijing Time), Scivita Medical’s headquarters, R&D and manufacturing plant was officially opened in Suzhou Industrial Park (SIP). This momentous occasion marks a significant milestone for Scivita Medical as it consolidates its key operations, encompassing R&D, production, marketing, doctor training, product display, and experiential activities. The … Read more

Waterdrop Inc. Announces First Quarter 2023 Unaudited Financial Results

by

BEIJING, June 2, 2023 /PRNewswire/ — Waterdrop Inc. (“Waterdrop”, the “Company” or “we”) (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced its unaudited financial results for the first quarter ended March 31, 2023. Financial and Operational Highlights for the First Quarter of 2023 Resilient … Read more

Sprout Pharmaceuticals Announces Release of Abstract Reporting Positive Interim Results for Flibanserin in Breast Cancer Patients Suffering from Low Libido for Poster Discussion at 2023 ASCO Annual Meeting

by

70% of women diagnosed with breast cancer report having sexual dysfunction, this includes disorders of sexual desire and sexual response. RALEIGH, N.C., June 2, 2023 /PRNewswire/ — Sprout Pharmaceuticals, Inc. a pharmaceutical company specializing in women’s sexual health today announced publication of abstract 12015 by the American Society of Clinical Oncology (ASCO). The abstract reporting … Read more

Thyme Care Joins CancerX Innovation Accelerator as Founding Member to Ignite Cancer Moonshot

by

National public-private partnership supports mission to slash cancer death rates by 50% over next 25 years; care navigation a crucial component for success Built by oncology industry veterans, Thyme Care joins initiative to help set the strategic direction and collaborate with key stakeholders to craft a cancer-free future Powered by a technology-enabled Care Team, Thyme … Read more

Los dispositivos de micromuestreo de Trajan cumplen la normativa IVDR en Europa y Reino Unido

by

Mitra® y hemaPEN ® reciben la certificación reglamentaria como productos sanitarios para la extracción remota de muestras de sangre en la asistencia sanitaria, los ensayos clínicos y los programas de monitorización domiciliaria en Europa y Reino Unido MELBOURNE, Australia, 2 de junio de 2023 /PRNewswire/ — Trajan Scientific and Medical, proveedor líder de productos y soluciones … Read more

Trajan’s Microsampling Devices Meet IVDR Compliance in Europe, UK

by

Mitra® and hemaPEN® receive regulatory certification as medical devices for remote blood sample collection in healthcare, clinical trials and home monitoring programs in Europe and United Kingdom. MELBOURNE, Australia, June 2, 2023 /PRNewswire/ — Trajan Scientific and Medical, a leading provider of analytical and life sciences products and solutions, today announced the regulatory approval of … Read more

TWi Biotechnology Exploring Promising Treatment for Granuloma Annulare (GA)

by

Company and Yale University Hospital seeking participants with GA for Phase 1 trials of medicine FDA-approved for other ailments NEW HAVEN, Conn., June 2, 2023 /PRNewswire/ — TWi Biotechnology (TWiB), a clinical stage biopharmaceutical company specializing in development of repositioned drugs for unmet medical needs, is currently seeking participants for a Phase 1 clinical trial … Read more

Trajans Microsampling-Geräte erfüllen die IVDR-Anforderungen in Europa und dem Vereinigten Königreich

by

Mitra® und hemaPEN ® erhalten die behördliche Zulassung als Medizinprodukte für die Remote-Blutprobenentnahme im Gesundheitswesen, für klinische Studien und für Überwachungsprogramme zu Hause in Europa und im Vereinigten Königreich. MELBOURNE, Australien, 2. Juni 2023 /PRNewswire/ — Trajan Scientific and Medical, ein führender Anbieter von analytischen und Life Sciences-Produkten und -Lösungen, gab heute die behördliche Zulassung seiner … Read more

Sobi to present new data at the 2023 EHA congress

by

STOCKHOLM, June 2, 2023 /PRNewswire/ — Sobi® will present data at the EHA (European Haematology Association) hybrid congress taking place in Frankfurt, Germany 8-11 June, 2023, highlighting the company’s commitment in rare haematological diseases. During the congress, Sobi will present important new data on haemophilia, immune thrombocytopenia, relapsed or refractory diffuse large b-cell lymphoma (DLBCL), and paroxysmal … Read more

Medivir has completed the dose escalation part (phase 1b) of the 1b/2a study in HCC and focuses on the combination of fostrox and Lenvima

by

STOCKHOLM, June 2, 2023 /PRNewswire/ —  Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces today that a safe dose has been established for treatment with the drug candidate fostroxacitabine bralpamide (fostrox) in combination with Keytruda® in the initial dose escalation … Read more